VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $300,262 | -10.7% | 11,158 | -0.1% | 0.04% | -2.3% |
Q2 2023 | $336,389 | -12.6% | 11,172 | -6.1% | 0.04% | -17.3% |
Q1 2023 | $385,040 | +84.2% | 11,902 | +82.2% | 0.05% | +160.0% |
Q4 2021 | $209,000 | -63.3% | 6,532 | -73.6% | 0.02% | -84.8% |
Q1 2020 | $570,000 | +4.8% | 24,720 | +4.4% | 0.13% | -26.7% |
Q3 2017 | $544,000 | +63.9% | 23,670 | +57.5% | 0.18% | +71.4% |
Q2 2017 | $332,000 | +56.6% | 15,029 | +60.1% | 0.10% | +26.5% |
Q1 2017 | $212,000 | – | 9,385 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |